Antibody Prophylaxis and Therapy of Flavivirus Infection

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$969,452.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43AI060217-01
Agency Tracking Number:
AI060217
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
L2 DIAGNOSTICS, LLC
L2 DIAGNOSTICS, LLC, BOX 8175, NEW HAVEN, CT, 94904
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 RAYMOND Koski
 (203) 589-2029
 RAYMOND.KOSKI@L2DX.COM
Business Contact
 MARTIN MATTESSICH
Phone: (203) 737-1952
Email: MJMATT@IX.NETCOM.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The overall goal of this project is to develop antibody therapy and prophylaxis to treat and prevent life-threatening flavivirus infections. West Nile virus is the focus of Phase I studies. Our working hypothesis is t

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government